CANDIDÍASE VULVOVAGINAL RECORRENTE: REVISÃO INTEGRATIVA SOBRE O PERFIL DAS MULHERES E TRATAMENTOS

Read full text Summarise with VIRAT
Authors: Ellen Viana Piao, Isabela Lucena Zapaterra, Julia do Carmo Fernandes
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Recurrent Vulvovaginal Candidiasis (RVVC) is a fungal infection that affects millions of women, negatively impacting their physical, emotional, and sexual health. Primarily caused by Candida albicans, it requires individualized treatment approaches due to increasing antifungal resistance. This review analyzes the profile of affected women and the therapeutic options available. OBJECTIVES: To analyze factors associated with Recurrent Vulvovaginal Candidiasis, focusing on the profile of affected women and treatments described in the scientific literature. METHODS: This study was conducted as an integrative review on “Recurrent Vulvovaginal Candidiasis: an integrative review of women’s profiles and treatment strategies.” Articles were retrieved from online databases, particularly PubMed, SciELO, and the Virtual Health Library (BVS), using descriptors established by DeCS/MeSH: “Vulvovaginal Candidiasis,” “Recurrence,” “Risk Factors,” and “Therapeutics.” RESULTS/DISCUSSION: Based on the selected databases, a total of five articles were included. RVVC predominantly affects women of reproductive age; however, its occurrence has also been observed in older age groups, possibly related to the use of Hormone Replacement Therapy. The analysis indicates that factors such as frequent sexual activity, antibiotic use, hormonal changes, immunological dysfunction, and genetic predisposition contribute to recurrence. Although fluconazole remains the most commonly used suppressive treatment, its effectiveness is limited, with high recurrence rates after discontinuation and increasing antifungal resistance, particularly in infections caused by non-albicans species. Self-medication further exacerbates this scenario, hindering clinical management. CONCLUSION: The findings reinforce the importance of individualized therapeutic approaches, accurate identification of fungal species, and the adoption of educational and preventive strategies. There is also a growing need for alternative therapies, such as immunomodulators and vaccines, to expand treatment options and improve the effective control of RVVC, thereby reducing its impact on women’s health and quality of life.

Fields of Study & Subjects

Antifungal resistance and susceptibility Reproductive tract infections research Urinary Tract Infections Management

Publication details

Pages
357–368
Publication date
24 March 2026
Language
EN
Document type
Book chapter